LanZhou University
121
21
23
29
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.8%
1 terminated/withdrawn out of 121 trials
96.7%
+10.1% vs industry average
8%
10 trials in Phase 3/4
7%
2 of 29 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (121)
Plasma Exosome RNA to Diagnose Prostate Cancer
Role: collaborator
Probiotic Yogurt in Patients With Chronic Cholecystitis
Role: lead
Gansu Nurses' Health Cohort Study
Role: lead
Recurrence After Gastric and Intestinal Polyp Resection
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
POD Risk for Colorectal Cancer Surgery
Role: lead
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Role: collaborator
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
Role: collaborator
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Role: collaborator
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
Role: collaborator
Modified Tumor-free Techniques Operation to Cervical Cancer
Role: collaborator
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Role: collaborator
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
Role: lead
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Role: collaborator
68Ga-PSMA PET in the Renal Cell Carcinoma
Role: collaborator
Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy
Role: lead
Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)
Role: collaborator
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
Role: collaborator
Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients
Role: lead
A Predictive Model for Midwives' C F: A Cross-Sectional Study
Role: lead